Skip to main content
SpringerLink
Log in

Developmental genetics

  • Published:
Experientia Aims and scope Submit manuscript

Summary

Of particular concern to the human geneticist are the effects of genetic abnormalities on development. To gain an understanding of these effects it is necessary to engage in a reciprocal process of using knowledge of normal developmental events to elucidate the mechanisms operative in abnormal situations and then of using what is learned about these abnormal situations to expand our understanding of the normal. True developmental genes have not been described in man, although it is likely that they exist, but many developmental abnormalities are ascribable to mutations in genes coding for enzymes and structural proteins. Some of these even produce multiple malformation syndromes with dysmorphic features. These situations provide a precedent for asserting that not only monogenic developmental abnormalities, but also abnormalities resulting from chromosome imbalance must ultimately be explicable in molecular terms. However, the major problem confronted by the investigator interested in the pathogenesis of any of the chromosome anomaly syndromes is to understand how the presence of an extra set of normal genes or the loss of one of two sets of genes has an adverse effect on development. Several molecular mechanisms for which limited precedents exist may be considered on theoretical grounds. Because of the difficulties in studying developmental disorders in man, a variety of experimental systems have been employed. Particularly useful has been the mouse, which provides models for both monogenic and aneuploidy produced abnormalities of development. An example of the former is the mutation oligosyndactylism which in the heterozygous state causes oligosyndactyly and in the homozygous state causes early embryonic mitotic arrest. All whole arm trisomies and monosomies of the mouse can be produced experimentally, and of special interest is mouse trisomy 16 which has been developed as an animal model of human trisomy 21 (Down syndrome). In the long run, the most direct approach to elucidating the genetic problems of human development will involve not only the study of man himself but also of the appropriate experimental models in other species.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Cancer Society, Cancer Statistics — 1982. CA: Cancer J. Clinicians32 (1982) 30.

    Google Scholar 

  2. Aoki, N., Moroi, M., Sakata, Y., Yoshida, N., and Matsude, M., Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J. clin. Invest.61 (1978) 1186–1195.

    Article  Google Scholar 

  3. Barsh, G.S., David, K.E., and Byers, P.H., Type I osteogenesis imperfecta: A nonfunctional allele for pro α1(I) chains of type I procollagen. Proc. natn. Acad. Sci. USA79 (1982) 3838–3842.

    Article  Google Scholar 

  4. Bartley, J.A., and Epstein, C.J., Gene dosage effect for glycinamide ribonucleotide synthetase in human fibroblasts trisomic for chromosome 21. Biochem. biophys. Res. Commun.93 (1980) 1286–1289.

    Article  Google Scholar 

  5. Beck, M., Glössl, J., Rüter, R., and Kresse, H., Abnormal proteodermatan sulfate in three patients with Coffin-Lowry syndrome. Pediatr. Res.17 (1983) 926–929.

    Article  Google Scholar 

  6. Becker, M.A., Losman, M.J., Itkin, P., and Simkin, P.A., gout with superactive phophoribosylpyrophosphate synthetase due to increased enzyme catalytic rate. J. Lab. clin. Med.99 (1982) 495–511.

    Google Scholar 

  7. Biddle, F.G., and Fraser, F.C., Genetics of cortisone-induced cleft palate in the mouse — Embryonic and maternal effects. Genetics84 (1976) 743–754.

    Article  Google Scholar 

  8. Blau, H.M., Chin, C.-P., and Webster, C., Cytoplasmic activation of human nuclear genes in stable heterokaryons. Cell32 (1983) 1171–1180.

    Article  Google Scholar 

  9. Böhn, N., Vy, J., Kiessling, M., and Lehnert, W., Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur. J. Paediatr.139 (1982) 60–65.

    Article  Google Scholar 

  10. Bond, D.J., and Chandley, A.C., Aneuploidy, Oxford University Press, Oxford 1983.

    Google Scholar 

  11. Boucek, R.J., Noble, N.L., Gunja-Smith, Z., and Butler, W.T., The Marfan syndrome: A deficiency in chemically stable collagen crosslinks. N. Engl. J. Med.305 (1981) 988–991.

    Article  Google Scholar 

  12. Boué, J., Boué, A., and Lazar, P., Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology12 (1975) 11–26.

    Article  Google Scholar 

  13. Boué, J., Deluchat, C.C., Nicolas, H., and Boué, A., Prenatal losses of trisomy 21, in: Trisomy 21. An International Symposium, pp. 183–193. Eds G.R. Burgio, M. Fracarro, L. Tiepolo and U. Wolf. Human Genetics Supplement 2. Springer-Verlag, Berlin 1981.

    Google Scholar 

  14. Buehler, B., Epoxide hydralase activity and fetal hydantoin syndrome. Proc. Greenwood Genet. Center3 (1984) 109–110.

    Google Scholar 

  15. Byers, P.H., Bonadio, J.F., Steinman, B., Barsh, G.S., Holbrook, K.A., Greenberg, C., Rowe, D.W., and Gelinas, R., Molecular heterogeneity in perinatal lethal osteogenesis imperfecta (OI type II). Am. J. hum. Genet.35 (1983) 39A.

    Google Scholar 

  16. Byers, P.H., Siegel, R.C., Peterson, K.E., Rowe, D.W., Holbrook, K.A., Smitz, L.T., Chang, Y.H., and Fu, J.C.C., Marfan syndrome: Abnormal α2 chains in type I collagen. Proc. natn. Acad. Sci. USA78 (1981) 7745–7749.

    Article  Google Scholar 

  17. Caviness, V.S. Jr, and Rakic, P., Mechanisms of cortical development: A view from mutations in mice. A. Rev. Neurosci.1 (1978) 297–326.

    Article  Google Scholar 

  18. Cederbaum, S.D., Kaitila, I., Rimoin, D.L., and Stiehm, E.R., The chondroosseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J. Pediatr.89 (1976) 737–742.

    Article  Google Scholar 

  19. Committee on Comparative Gene Mapping. Report of the Committee of Comparative Gene Mapping. Human Gene Mapping 8. Cytogenet. Cell Genet.40 (1985) 536–566.

    Article  Google Scholar 

  20. Costa, T., Scriver, C.R., and Childs, B., Phenotypic expression of errors in morphogenesis. Proc. Greenwood Genet. Center3 (1984) 136.

    Google Scholar 

  21. Coyle, J.T., Gearhard, J.D., Oster-Granite M.L., Singer, H.S., and Moran, T.H., Brain neurotransmitters: Implications for Down syndrome from studies of mouse trisomy 16, in: The Neurobiology of Down Syndrome, pp. 153–169. Ed. C.J. Epstein. Raven Press, New York 1986.

    Google Scholar 

  22. Cox, D.R., and Epstein, C.J., Comparative gene mapping of human chromosome 21 and mouse chromosome 16. Ann. N.Y. Acad. Sci.450 (1985) 169–177.

    Article  Google Scholar 

  23. Cox, D.R., Epstein, L.B., and Epstein, C.J., Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16. Proc. natn. Acad. Sci. USA77 (1980) 2168–2172.

    Article  Google Scholar 

  24. Cox, D.R., Goldblatt, D., and Epstein, C.J., Chromosomal assignment of mouse PRGS: Further evidence for homology between mouse chromosome 16 and human chromosome 21. Am. J. hum. Genet.33 (1981) 145A.

    Google Scholar 

  25. Cox, D.R., Kawashima, H., Vora, S., and Epstein, C.J., Regional mapping ofSOD-1, PRGS, andPFK-L on human chromosome 21: Implications for the role of these genes in the pathogenesis of Down syndrome. Am. J. hum. Genet.35 (1983) 188A.

    Google Scholar 

  26. Cox, D.R., Smith, S.A., Epstein, L.B., and Epstein, C.J., Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): Production of viable trisomy 16↔diploid mouse chimeras. Devl Biol.101 (1984) 416–424.

    Article  Google Scholar 

  27. Dyban, A.P., and Baranov, V.S., The Cytogenetics of Mammalian Embryogenesis. Nauka, Moscow 1978.

    Google Scholar 

  28. Edelman, G.M. and Chuong, C.-M., Embryonic to adult conversion of neural cell adhesion molecules in normal and staggerer mice. Proc. natn. Acad. Sci. USA79 (1982) 7036–7040.

    Article  Google Scholar 

  29. Edwards, J.H., The mutation rate in man. Prog. med. Genet.10 (1974) 1–16.

    Google Scholar 

  30. Elmer, W.A., and Wright, J.T., Changes in plasma membrane proteins and glycoproteins during normal and brachypod mouse limb development, in: Limb Development and Regeneration, Part A, pp. 355–364. Eds J.F. Fallon, A.I. Caplan and R.O. Kelley. A. R. Liss, New York 1983.

    Google Scholar 

  31. Epstein, C.J., Inferring from modes of inheritance to the mechanisms of genetic disease, in: Pathogenesis of Human Muscular Dystrophies. Proceedings of the Fifth International Scientific Conference of the Muscular Dystrophy Association, pp. 9–22. Ed. L.P. Rowland. Excerpta Medica, Amsterdam-Oxford 1977.

    Google Scholar 

  32. Epstein, C.J., Developmental mechanisms and abnormalities: toward a developmental genetics of man, in: Birth Defects, pp. 387–395. Eds J.W. Littlefield and J. deGrouchy. Excerpta Medica. Amsterdam-Oxford 1978.

    Google Scholar 

  33. Epstein, C.J., Animal models for autosomal trisomy, in Trisomy 21 (Down syndrome): Research Perspectives pp. 263–273. Eds F.F. de la Cruz and P.S. Gerald. University Park Press, Baltimore 1981.

    Google Scholar 

  34. Epstein, C.J., Inactivation of the X chromosome, in: The Biology of Normal Human Growth, pp. 79–90. Eds M. Ritzén, A. Aperia, K. Hall A. Larsson, A. Zetterberg and R. Zetterström. Raven Press, New York 1981.

    Google Scholar 

  35. Epstein, C.J., Down's syndrome and Alzheimer's disease: Implications and approaches, in: Banbury Report 15: Biological Aspects of Alzheimer's Disease, pp. 169–182. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 1982.

    Google Scholar 

  36. Epstein, C.J., Consequences of the state of X-chromosome activity, in: Cytogenetics of the Mammalian X Chromosome, Part A. Basic Mechanisms of X Chromosome Behavior, pp. 341–353. Ed. A.A. Sandberg, A. R. Liss, New York 1983.

    Google Scholar 

  37. Epstein, C.J., The X chromosome in development, in: Cytogenetics of the Mammalian X Chromosome. Part A. Basic Mechanisms of X Chromosome Behavior, pp. 51–65. Ed. A.A. Sandberg. A.R. Liss, New York 1983.

    Google Scholar 

  38. Epstein, C.J., The mouse trisomies: Experimental systems for the study of aneuploidy, in: Issues and Reviews in Teratology, vol. 3, pp. 171–217. Ed. H. Kalter, Plenum, New York 1985.

    Chapter  Google Scholar 

  39. Epstein, C.J., The Consequences of Chromosome Imbalance. Principles, Mechanisms, and Models. Cambridge University Press, New York 1986.

    Book  Google Scholar 

  40. Epstein, C.J., and Epstein, L.B., Genetic control of the response to interferon in man and mouse. Lymphokines8 (1983) 277–301.

    Google Scholar 

  41. Epstein, C.J. and Travis, B., Preimplantation lethality of monosomy for mouse chromsome 19. Nature280 (1979) 144–145.

    Article  Google Scholar 

  42. Epstein, C.J., Cox, D.R., and Epstein, L.B., Mouse trisomy 16: An animal model of human trisomy 21 (Down syndrome). Ann. N.Y. Acad. Sci.450 (1985) 157–168.

    Article  Google Scholar 

  43. Epstein, C.J., Cox, D.R., Epstein, L.B., and Magnuson, T.R., Animal models for human chromosome disorders, in: Research Perspectives in Cytogenetics, pp. 75–95. Eds R.S. Sparkes and F.F. de la Cruz. University Park Press, Baltimore 1984.

    Google Scholar 

  44. Epstein, C.J., Epstein, L.B., Cox, D.R., and Weil, J., Functional implications of gene dosage effects in trisomy 21, in: Trisomy 21. An International Symposium, pp. 155–172. Eds G.R. Burgio, M. Fraccaro, L. Tiepolo and U. Wolf. Human Genetics, Supplement 2. Springer-Verlag, Berlin 1981.

    Google Scholar 

  45. Epstein, C.J., Hofmeister, B.G., Yee, D., Smith, S.A., Philip, R., Cox, D.R., and Epstein, L.B., Stem cell deficiencies and thymic abnormalities in fetal mouse trisomy 16. J. expl Med.162 (1985) 695–712.

    Article  Google Scholar 

  46. Epstein, C.J., McManus, N.H., Epstein, L.B., Branca, A.A., D'Alessandro, S.B., and Baglioni, C., Direct evidence that the gene product of the human chromosome 21 locus,IFRC, is the interferon α-receptor. Biochem. biophys. Res. Commun.107 (1982) 1060–1066.

    Article  Google Scholar 

  47. Epstein, C.J., Smith, S., and Cox, D.R., Production and properties of mouse trisomy 15↔2n chimeras. Devl Genet.4 (1984) 159–165.

    Article  Google Scholar 

  48. Epstein, C.J., Smith, S.A., Zamora, T., Sawicki, J.A., Magnuson, T.R., and Cox, D.R., Production of viable adult trisomy 17↔diploid mouse chimeras. Proc. natn. Acad. Sci. USA79 (1982) 4376–4380.

    Article  Google Scholar 

  49. Epstein, L.B., and Epstein, C.J., T-lymphocyte function and sensitivity to interferon in trisomy 21. Cell. Immun.51 (1980) 303–318.

    Article  Google Scholar 

  50. Feaster, W.W., Kwok, L.W., and Epstein, C.J., Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21. Am. J. hum. Genet.29 (1977) 563–570.

    Google Scholar 

  51. Fraser, F.C., The multifactorial/threshold concept-uses and misuses. Teratology14 (1976) 267–280.

    Article  Google Scholar 

  52. Friedman, A., Bethzhold, J., Hong, R., Gilbert, E., Visekul, C., and Opitz, J.M., Clinopathologic conference: A three-month-old infant with failure to thrive, hepatomegaly, and neurologic impairment. Am. J. med. Genet.7 (1980) 171–186.

    Article  Google Scholar 

  53. Goldstein, J.L., and Brown, M.S., Familial hypercholesterolemia. A genetic regulatory defect in cholesterol metabolism. Am. J. Med.58 (1975) 147–150.

    Article  Google Scholar 

  54. Goodman, S.I., Reale, M., and Berlow, S., Glutaric acidemia type II: A form with deleterious intrauterine effects. J. Pediatr.102 (1983) 411–413.

    Article  Google Scholar 

  55. Green, M.C., Catalog of mutant genes and polymorphic loci, in: Genetic Variants and Strains of the Laboratory Mouse, pp. 8–278. Ed. M.C. Green. Gustav Fischer Verlag, Stuttgart 1981.

    Google Scholar 

  56. Gropp, A., Clinical and experimental pathology of fetal wastage, in: Human Reproduction. Proceedings of the IIIrd World Congress, pp. 208–216. Eds K. Semm and L. Mettler. Excerpta Medica, Amsterdam 1981.

    Google Scholar 

  57. Gropp, A., Value of an animal model for trisomy. Virchows Arch.395 (1982) 117–131.

    Article  Google Scholar 

  58. Gropp, A., and Winking, H., Robertsonian translocations: cytology, meiosis, segregation patterns and biological consequences of heterozygosity. Zool. Soc. London Symp.47 (1981) 141–181.

    Google Scholar 

  59. Gropp, A., Giers, D., and Kolbus, U., Trisomy in the fetal back cross progeny of male and female metacentric heterozygotes in the mouse. I. Cytogenet. Cell Genet.13 (1974) 511–535.

    Article  Google Scholar 

  60. Gropp, A., Kolbus, U., and Giers, D., Systematic approch to the study of trisomy in the mouse. II. Cytogenet. Cell Genet.14 (1975) 42–62.

    Article  Google Scholar 

  61. Grüneberg, H., Genetical studies on the skeleton of the mouse. XXVII. The development of oligosyndactylism. Genet. Res.2 (1961) 33–42.

    Article  Google Scholar 

  62. Halal, F., Quenneville, G., Laurin, S., and Loulou, G., Clinical and genetic aspects of antithrombin III deficiency, Am. J. med. Genet.14 (1983) 737–750.

    Article  Google Scholar 

  63. Hassold, T.J., Matsuyama, A., Newlands, I.M., Matsuura, J.S., Jacobs, P.A., Manuel, B., and Tsue, J., A cytogenetic study of spontaneous abortions in Hawaii. Ann. hum. Genet.41 (1978) 443–454.

    Article  Google Scholar 

  64. Herbst, E.W., Gropp, A., Nielsen, K., Hoppe, H., Freymann, M., and Pluznik, D.H., Reduced ability of mouse trisomy 16 stem cells to restore hemopoiesis in lethally irradiated animals, in: Experimental Hematology Today, pp. 119–126. Eds S.J. Baum, G.D. Ledney and S. Thierfelder. Karger, Basel 1982.

    Google Scholar 

  65. Heymans, H.S.A., Schutgens, R.B.H., Tan, R., van der Bosch, H., and Borst, P., Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature306 (1983) 69–70.

    Article  Google Scholar 

  66. Hollister, D.W., Byers, P.H., and Holbrook, K.A., Genetic disorders of collagen metabolism. Adv. hum. Genet.12 (1982) 1–87.

    Google Scholar 

  67. Holmes, E.B., Prospective counseling for hereditary malformations in newborns, in: Genetic Counseling, pp. 241–248. Eds H.A. Lubs and F.F. de la Cruz. Raven Press, New York 1977.

    Google Scholar 

  68. Hook, E.B., and Hamerton, J.H., The frequency of chromosome abnormalities detected in consecutive newborn studies-differences between studies — results by sex and by severity of phenotypic involvement, in: Population Cytogenetics: Studies in Humans, pp. 63–80. Eds E.B. Hook and I.H. Porter. Academic Press, New York 1977.

    Google Scholar 

  69. Joyner, A.L., Kornberg, T., Coleman, K.G., Cox, D.R., and Martin, G.R., Expression during embryogenesis of a mouse gene with sequence homology to the Drosophilaengrailed gene. Cell43 (1985) 29–37.

    Article  Google Scholar 

  70. Joyner, A.L., Lebo, R.V., Kan, Y.W., Tjian, R., Cox, D.R. and Martin, G.R., Comparative chromosome mapping of a conserved homoeo box region in mouse and human. Nature314 (1985) 173–175.

    Article  Google Scholar 

  71. Kadam, K.M., Genetical studies on the skeleton of the mouse. XXXI. The muscular anatomy of syndactylism and oligosyndactylism. Genet. Res.3 (1962) 139–156.

    Article  Google Scholar 

  72. Kahler, S.G., Lengowski, K., and Roe, C.R., Glutaric aciduria type II (multiple acyl-CoA-dehydrogenase deficiency): a teratogenic and carcinogenic inborn error of metabolism. Proc. Greenwood Genet. Center3 (1984) 87.

    Google Scholar 

  73. Kalter, H., A compendium of the genetically induced congenital malformations of the house mouse. Teratology21 (1980) 397–429.

    Article  Google Scholar 

  74. Kelley, R.I., The cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects. Am. J. med. Genet.16 (1983) 503–517.

    Article  Google Scholar 

  75. Klose, J., and Putz, B., Analysis of two-dimensional protein patterns from mouse embryos with different trisomies. Proc. natn. Acad. Sci. USA80 (1983) 3753–3757.

    Article  Google Scholar 

  76. Lawrence, P.A., and Morata, G., The elements of the bithorax complex. Cell35 (1983) 595–601.

    Article  Google Scholar 

  77. Levitt, P., and Noebels, J.L., Mutant mouse tottering: Selective increase of locus ceruleus axons in a defined single-locus mutation. Proc. natn. Acad. Sci. USA78 (1981) 4630–4634.

    Article  Google Scholar 

  78. McKusick, V.A., and Neufeld, E.F., The mucopolysaccharide storage diseases, in: The Metabolic Basis of Inherited Disease, 5th edn, pp. 751–777. Eds J.B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson, J.L. Goldstein and M.S. Brown. McGraw-Hill, New York 1983.

    Google Scholar 

  79. Magnuson, T., Genetic abnormalities and early mammalian development, in: Development in Mammals, vol. 5, pp. 209–249. Ed. M.H. Johnson. Elsevier, Amsterdam 1983.

    Google Scholar 

  80. Magnuson, T., and Epstein, C.J., Genetic control of early mammalian development. Biol. Rev.56 (1981) 369–408.

    Article  Google Scholar 

  81. Magnuson, T., and Epstein, C.J., Oligosyndactyly: A lethal mutation in the mouse that results in mitotic arrest early in development. Cell38 (1984) 823–833.

    Article  Google Scholar 

  82. Magnuson, T., Debrot, S., Dimpfl, J., Zweig, A., Zamora, T., and Epstein, C.J., The early lethality of autosomal monosomy in the mouse. J. expl Zool.236 (1985) 353–360.

    Article  Google Scholar 

  83. Magnuson, T., Smith, S., and Epstein, C.J., The development of monosomy 19 mouse embryos. J. Embryol. expl. Morph.69 (1982) 223–236.

    Google Scholar 

  84. Mahowald, A.P., and Hardy, P.A., Genetics of Drosophila embryogenesis. A. Rev. Genet.19 (1985) 149–177.

    Article  Google Scholar 

  85. Meuwissen, H.J., Pollara, B., and Pickering, R.J., Combined immunodeficiency disease associated with adenosine deaminase deficiency. J. Pediatr.86 (1975) 169–181.

    Article  Google Scholar 

  86. Nebert, D.W., Genetic differences in drug metabolism: possible importance in teratogenesis, in: Phenytoin-Induced Teratology and Gingival Pathology, pp. 113–128. Eds T.M. Hassell M.C. Johnston and K.H. Dudley. Raven Press, New York 1980.

    Google Scholar 

  87. Nielsen, J., Chromosome examination of newborn children. Purpose and ethical aspects. Humangenetik26 (1975) 215–222.

    Article  Google Scholar 

  88. Miyabara, S., Gropp, A., and Winking, H., Trisomy 16 in the mouse fetus associated with generalized edema, cardiovascular and urinary tract anomalies. Teratology25 (1982) 369–380.

    Article  Google Scholar 

  89. Opitz, J.M., The developmental field concept in clinical genetics. J. Pediatr.101 (1982) 805–809.

    Article  Google Scholar 

  90. Oster-Granite, M.L., Gearhart, J.D., and Reeves, R., Neurological consequences of trisomy 16 in mice, in: The Neurobiology of Down Syndrome, pp. 137–151. Ed. C.J. Epstein, Raven Press, New York 1986.

    Google Scholar 

  91. Oster-Granite, M.L., Reed, W.D., Collins, R.M., Jr, and Ozand, P.T., The brain catecholamine system in mouse trisomy 16. Pediatr. Res.17 (1983) 139A.

    Google Scholar 

  92. Paigen, K., Genetic factors in developmental regulation, in: Physiological Genetics, pp. 1–61. Ed. J.G. Scandalios. Acadmeic Press, New York 1979.

    Google Scholar 

  93. Paterson, H.F., In vivo and in vitro studies on the early embryonic lethal oligosyndactylism (Os) in the mouse. J. Embryol. expl. Morh.52 (1979) 115–125.

    Google Scholar 

  94. Philip, R., Berger, A.C., McManus, N.H., Warner, N.H., Peacock, M.A., and Epstein, L.B., Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). J. Immun.136 (1986) 1661–1667.

    Article  Google Scholar 

  95. Prockop, D.J., Williams, C., deWet, W.J., Sippola, M., Uitto, J., and Pihlajaniemi, T., Shortening and lengthening of pro α chains of type I procollagen in osteogenesis imperfecta. Clin. Res.31 (1983) 533A.

    Google Scholar 

  96. Rabin, M., Hart, C.P., Ferguson-Smith, A. McGinnis, W., Levin, M., and Ruddle, F.H., Two homeo box loci mapped in evolutionarily related mouse and human chromosomes. Nature314 (1985) 175–178.

    Article  Google Scholar 

  97. Rehder, H., Pathology of trisomy 21 — with particular reference to persistent common atrioventricular canal of the heart, in: Trisomy 21. An International Symposium, pp. 155–172. Eds G.R. Burgio, M. Fraccaro, L. Tiepolo and U. Wolf. Human Genetics, Supplement 2. Springer-Verlag, Berlin 1981.

    Google Scholar 

  98. Rowe, D.W., Shapiro, J.R., Poirier, M., and Schlesinger, S., Diminished type I collagen synthesis and reduced alpha 1 (I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (Type I) osteogenesis imperfecta. J. clin. Invest.76 (1985) 604–611.

    Article  Google Scholar 

  99. Sankaranarayanan, K., Evaluation and re-evaluation of genetic radiation hazards in man. III. Other relevant data and risk assessment. Mutat. Res.35 (1976) 387–414.

    Article  Google Scholar 

  100. Santos, M.J., Ojeda, J.M., Garrido, J., and Leighton, F., Peroxisomal organization in normal and cerebrohepatorenal (Zellweger) syndrome fibroblasts. Proc. natn. Acad. Sci. USA82 (1985) 6556–6560.

    Article  Google Scholar 

  101. Sassa, S., and Kappas, A., Genetic, metabolic, and biochemical aspects of the porphyrias. Adv. hum. Genet.11 (1981) 121–231.

    Google Scholar 

  102. Scott, M.P., Weiner, A.J., Hazelrigg, J.I., Polesky, B.A., Pirrotta, V., Scalenghe, F., and Kaufman, T., The molecular organization of theAntennapedia locus of Drosophila. Cell35 (1983) 763–776.

    Article  Google Scholar 

  103. Shapiro, B., Down syndrome — a disruption of homeostasis. Am. J. med. Genet.14 (1983) 241–269.

    Article  Google Scholar 

  104. Shum, S., Jensen, N.M., and Nebert, D.W., The murineAh locus: In utero toxicity and teratogenesis associated with genetic differences in benzo(a)pyrene metabolism. Teratology20 (1979) 365–376.

    Article  Google Scholar 

  105. Smith, G.F., and Berg, J.M., Down's Anomaly, 2nd edn. Churchill-Livingstone, Edinburgh 1975.

    Google Scholar 

  106. Spranger, J., Benirschke, K., Hall, J.G., Lenz, W., Lowry, R.B., Opitz, J.M., Pinsky, L., Schwartzacher, H.G., and Smith, D.W., Errors of morphogenesis: Concepts and terms. Recommendations of an International Working Group. J. Pediatr.100 (1982) 160–165.

    Article  Google Scholar 

  107. Stewart, A.D., and Stewart, J., Studies on syndrome of diabetes insipidus associated with oligosyndactyly in mice. Am. J. Physiol.217 (1969) 1191–1198.

    Article  Google Scholar 

  108. Strickler, S.M., Miller, M.A., Andermann, E., Dansky, L.V., Seni, M.-H., and Spielberg, S.P., Genetic predisposition to phenytoin-induced birth defects. Lancet2 (1985) 746–749.

    Article  Google Scholar 

  109. Summitt, R.L., Chromosome 21. Specific segments that cause the phenotype of Down syndrome, in: Trisomy 21 (Down syndrome). Research Perspectives, pp. 225–235. Eds F.F. de la Cruz and P.S. Gerald, University Park Press, Baltimore 1981.

    Google Scholar 

  110. Sykes, B., Collagen and inherited connective tissue diseases. Nature305 (1983) 764.

    Article  Google Scholar 

  111. Tchernia, G., Mohandas, N., and Shohet, S. B., Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability. J. clin. Invest.68 (1981) 454–460.

    Article  Google Scholar 

  112. Temtamy, S. A., and McKusick, V. A., The Genetics of Hand Malformations. Birth Defects: Orig. Art. Ser.14 (3). A. R. Liss. New York 1978.

    Google Scholar 

  113. Van Keuren, M. L., Merril, C. K., and Goldman, D., Proteins affected by chromosome 21 and ageingin vitro, in: Gene Expression in Normal and Transformed Cells, pp. 349–378. Eds J. E. Celis and R. Bravo. Plenum, New York 1983.

    Chapter  Google Scholar 

  114. Van Valen, P., Oligosyndactylism, an early embryonic lethal in the mouse. J. Embryol. expl Morph.15 (1966) 119–124.

    Google Scholar 

  115. Weatherall, D. J., and Clegg, J. B., The Thalassaemia Syndromes, 3rd edn. Blackwell, Oxford 1981.

    Google Scholar 

  116. Weil, J., and Epstein, C. J., The effects of trisomy 21 on the patterns of polypeptide synthesis in human fibroblasts. Am. J. hum. Genet.31 (1979) 478–488.

    Google Scholar 

  117. Weil, J., Epstein, L. B., and Epstein, C. J., Synthesis of interferon-induced polypeptides in normal and chromosome-21-aneuploid human fibroblasts: relationship to relative sensitivities in antiviral assays. J. Interferon Res.1 (1980) 111–124.

    Article  Google Scholar 

  118. Weil, J., Tucker, G., Epstein, L. B., and Epstein, C. J., Interferon induction of (2−–5′) oligoisoadenylate synthetase in diploid and trisomy 21 human fibroblasts: Relation to dosage of the interferon receptor gene (IFRC). Hum. Gent.65 (1983) 108–111.

    Article  Google Scholar 

  119. Weiss, M. C., The analysis of cell differentiation by hybridization of somatic cells. Results and Problems in Cell Differentiation11 (1980) 87–92.

    Article  Google Scholar 

  120. Wenstrup, R. J., Hunter, A., and Byers, P. H., Abnormality in pro α2(I) chain of type I collagen in a form of osteogenesis imperfecta (OI). Am. J. hum. Genet.35 (1983) 57A.

    Google Scholar 

  121. Willinger, M., Margolis, D. M., and Sidman, R. L., Neuronal differentiation in cultures of weaver (wv) mutant mouse cerebellum. J. supramol. Struct. cell. Biochem.17 (1981) 79–86.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pediatrics and of Biochemistry and Biophysics, University of California, 94143-0106, San Francisco, California, USA

    C. J. Epstein

Authors
  1. C. J. Epstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Acknowledgments. This review was written while the author was a Henry J. Kaiser Senior Fellow at the Center for Advanced Study in the Behavioral Sciences, Palo Alto, California. This work was supported by grants from the National Institutes of Health (GM-24309, HD-03132, HD-15583, HD-17001) and the American Cancer Society (CD-119) and by a contract from the National Institute of Child Health and Human Development (NOI-HD-2858).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Epstein, C.J. Developmental genetics. Experientia 42, 1117–1128 (1986). https://doi.org/10.1007/BF01941286

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01941286

Key words

Search

Navigation